Infectious Diseases Clinical Trials, Studies and Research

As patients continue to be diagnosed with COVID-19, the disease caused by the coronavirus, Norton Healthcare is looking for ways to help them overcome the infection. Norton Healthcare was the first in the world to enroll COVID-19 patients in three separate clinical trials. Additional studies are either underway or will begin in the coming weeks.

Learn more about participating in a clinical trial at Norton Healthcare.

Recently Published Infectious Diseases Research from Norton Healthcare Physicians

Severe community-acquired pneumonia: current concepts and controversies
Critical Challenges: Respiratory Infections in Immunocompromised ICU Patients
A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease
Viewpoint: global antimicrobial stewardship accreditation is needed: the experience in Kentucky, USA
General Approach to Immunocompromised Patients with Pneumonia: Insights from the Latest Consensus Documents

Infectious Diseases Clinical Trials, Studies and Research

Infectious Diseases Clinical Trials, Studies and Research

Recently Published Infectious Diseases Research from Norton Healthcare Physicians

Related Stories

Norton Healthcare first in Louisville to unveil new treatment for esophageal cancer

Ways the community can help keep new mothers healthy

Patients finding hope, life-changing care at the Norton Neuroscience Institute Adult Neurodevelopmental Program

A heart for service: Joseph A. Lash, M.D., reflects on nearly 3 decades in cardiology